During the past decade, Nightingale Health plc conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nightingale Health plc" are "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "Nightingale Health plc" in a lesser frequency.

Most popular intervention types in "Nightingale Health plc" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Placebo product" (1 trials), "Plant stanol ester" (1 trials) and "Product that contains plant stanol ester" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nightingale Health plc" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nightingale Health plc". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nightingale Health plc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nightingale Health plc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".